Trulieve Faces Lawsuit Over Employee Firings in Florida

Dec.14.2022
Trulieve Faces Lawsuit Over Employee Firings in Florida
Trulieve, a multi-state marijuana operator based in Florida, faces a collective lawsuit for allegedly not providing adequate notice prior to employee layoffs.

Trulieve, a multi-state cannabis operator headquartered in Florida, recently terminated some of its employees in Gadsden County. This resulted in affected workers filing a collective lawsuit alleging that the company did not provide sufficient notice before their termination.


Trulieve, a Florida-based cannabis company, operates two cultivation sites in Quincy and a processing plant on Midway Island in Gadsden County. The company has not disclosed the number of employees who have been terminated but has stated that the move is aimed at reducing layoffs as the company continues to grow, according to the Tallahassee Democrat.


According to Trulieve spokesperson Steve Vancore, affected employees have been offered alternative jobs at the company's other factories in Jefferson and Madison counties. Those employees who were ultimately not able to secure another position will receive severance pay.


Vancore informed Democratic lawmakers in Tallahassee that the layoffs ultimately stemmed from Trulieve's acquisition of Harvest Health and Recreation, which is based in Arizona.


We merged and acquired Harvest a year ago," Vancore told the news media. "This was part of our consolidation strategy as we continue to develop in areas of redundancy and inefficiency. When you have 9,000 employees, this is indeed a measure to improve efficiency.


Last week, employees affected by layoffs filed a class-action lawsuit against Trulieve, alleging that the company failed to provide the required Worker Adjustment and Retraining Notification (WARN) Act notice regarding their termination.


According to Democrats in Tallahassee, the lawsuit alleges that if a company lays off "50 or more employees (excluding any part-time employees) at a single worksite within any 30-day period," it must provide a notice under the WARN Act.


According to a report by the Tampa Bay Times, the lawsuit was originally filed by attorney Tiffany Cruz on behalf of Langel O'Neil, who worked at Trulieve's Quincy facility. The plaintiff is seeking monetary compensation equivalent to the total amount of unpaid wages, salaries, commissions, bonuses, accrued vacation pay, accrued sick pay, and other benefits within 60 days after termination. This has been reported in the media.


Trulieve has contested these allegations, according to Tallahassee attorney and partner at Stearns Weaver Miller, Glenn Burhans Jr., who told the news media that Trulieve "has complied with all state and federal laws regarding the reduction of force.


In possible scenarios, Trulieve offers affected employees new positions at the same location or other locations within the area," he told the Tampa Bay Times. "If relocation is not feasible or not accepted, employees will receive severance pay.


In another statement provided to the news media, Trulieve expressed its commitment to the northwest region of Florida and highlighted the construction of a 750,000-square-foot facility in Jefferson County by the company.


According to a statement released by the company to the Tampa Bay Times, Trulieve has approximately 9,000 employees in the United States and is currently hiring for "additional positions in various fields".


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Product | Labeled “Built in the USA” Up to 60,000 Puffs: DOJO PUREX 60K Launches on U.S. Sales Channels
Product | Labeled “Built in the USA” Up to 60,000 Puffs: DOJO PUREX 60K Launches on U.S. Sales Channels
DOJO unveiled the PUREX 60K e-cigarette at TPE 2026 held in Las Vegas, United States. The product is labeled “Built in the USA,” supports up to 60,000 puffs, and features 16ml e-liquid capacity, a 1000mAh battery, and ECO and SMART output modes. It has gone live on DOJO’s official website and select U.S. online sales channels at a price of $18.99.
Apr.07 by 2FIRSTS.ai
FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
FDA CTP issued a May 7 statement on accelerating product review and improving PMTA efficiency, but did not push it via official X and newsletter until May 13, one day after FDA Commissioner Marty Makary’s resignation was confirmed. FDA has not explained the delay, and no public evidence links it directly to the leadership change. The timing is notable given CTP’s usual 24-hour distribution practice.
Special Report
May.14
Indonesian drug agency chief proposes ban on e-cigarettes and e-liquid containing harmful substances
Indonesian drug agency chief proposes ban on e-cigarettes and e-liquid containing harmful substances
Indonesian drug agency chief proposes ban on e-cigarette and e-liquid in new draft law, citing dangerous substances found.
Apr.08 by 2FIRSTS.ai
BAT New Zealand Says Illicit Tobacco Trade Drove Nearly 29% Revenue Decline in 2025
BAT New Zealand Says Illicit Tobacco Trade Drove Nearly 29% Revenue Decline in 2025
British American Tobacco New Zealand said the illicit tobacco trade is responsible for its profit halving and revenue falling between the 2024 and 2025 financial years. Financial results filed with the Companies Office show that BAT Holdings (New Zealand) recorded 2025 revenue of NZ$180.7 million, or about US$106.95 million based on the European Central Bank’s April 27, 2026 reference rates, down from NZ$254 million, or about US$150.33 million, in 2024.
Apr.28 by 2FIRSTS.ai
Glas Says FDA Scientific Review Backed Several Flavored Products Before Senior Leaders Blocked Them
Glas Says FDA Scientific Review Backed Several Flavored Products Before Senior Leaders Blocked Them
Glas says newly released internal FDA records show agency scientific reviewers supported authorization for several flavored G2 products before senior leadership halted them. According to documents obtained through a Freedom of Information Act request, FDA’s Office of Science first recommended marketing authorization for all eight products in December 2025 and later supported six of them in February 2026. FDA ultimately authorized only the G2 device and one tobacco-flavored pod in March.
Apr.23 by 2FIRSTS.ai
Italy Formally Submits Detailed Opinion to EU Obstructing Ireland's Disposable Vape Ban
Italy Formally Submits Detailed Opinion to EU Obstructing Ireland's Disposable Vape Ban
Italy's Ministry of Enterprises and Made in Italy has submitted a detailed opinion against Ireland's proposed "Public Health (Single Use Vapes) Bill 2025." Italy argued that the comprehensive ban on disposable vapes lacks scientific evidence, violates the EU principle of the free movement of goods, and conflicts with the existing Tobacco Products Directive.
Apr.10 by 2FIRSTS.ai